Successful treatment of invasive pulmonary aspergillosis in an immunocompetent host.
Immunocompromised individuals are susceptible to pulmonary Aspergillus infection, but invasive Aspergillus infection is extremely rare in the presence of normal immunity. A case of invasive pulmonary aspergillosis in an immunocompetent 57-year-old female who was successfully treated with liposomal amphotericin-B is reported here.
Polat
Gülru
G
Department of Respiratory Medicine, Chest Disease and Surgery Training and Research Hospital, Izmir, Turkey.
Urpek
Gülcan
G
Yilmaz
Ufuk
U
Büyükşirin
Melih
M
Karadağ Polat
Serpil
S
Uluer
Servet
S
Tibet
Gültekin
G
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D044963:Biopsy, Fine-Needle; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D008081:Liposomes; D008875:Middle Aged; D013902:Radiography, Thoracic; D013183:Sputum / Q000382:microbiology; D014057:Tomography, X-Ray Computed
D000935:Antifungal Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B